Evidence map›Paper›PMID 38968453›Full record

ArticleMedicine2024

Scleral bridging technique for preventing PreserFlo microshunt exposure: A case report.

Shunsuke Nakakura, Yuki Nagata, Yasuko Fujisawa, Yoshiaki Kiuchi

Abstract readCase Reports
In one paragraph

Article in Medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Shunsuke NakakuraDepartment of Ophthalmology, Saneikai Tsukazaki Hospital, Himeji, Japan.
Yuki NagataDepartment of Ophthalmology, Saneikai Tsukazaki Hospital, Himeji, Japan.
Yasuko FujisawaDepartment of Ophthalmology, Saneikai Tsukazaki Hospital, Himeji, Japan.
Yoshiaki KiuchiDepartment of Ophthalmology and Visual Sciences, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe use of the PreserFlo microshunt is gaining popularity owing to its ease of implantation and reduced need for postoperative intervention compared to conventional trabeculectomy. PATIENT CONCERNS: However, microshunt exposure remains a severe complication of PreserFlo surgery, particularly in patients with a thin Tenon capsule and conjunctiva. However, the actual thickness and intensity of the Tenon capsule or conjunctiva can be confirmed only during surgery. DIAGNOSIS: Exfoliation glaucoma with previous several glaucoma surgeries with thinner Tenon capsule or conjunctiva.

interventionsWe performed PreserFlo implantation with a surgical technique to recover a thin Tenon capsule and conjunctiva by creating a half-thickness rectangular scleral flap under the shunt and covering it over the microshunt until the distal part, similar to the bridge. OUTCOMES: The patient had better intraocular pressure control with positive cosmetic appearance using this technique.

conclusionThis technique will be beneficial for both preventing exposure and holding down the top, in addition to improving cosmetic appearance.

Indexed as

ScleraAgedConjunctivaExfoliation SyndromeFemaleGlaucoma Drainage ImplantsHumansIntraocular PressureMalePostoperative ComplicationsSurgical FlapsTenon CapsuleTrabeculectomy

Identifiers

PMID38968453
PMCPMC11224877

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.